Skip to main content

Table 1 Medical resource utilization and prescribed medications in 2008 (United Kingdom)

From: Prescribed therapy for asthma: therapeutic ratios and outcomes

 

R = 0%

0% < R < 50%

R ≥ 50%

p-value

All patients

    

Number of patients

6,996

14,903

16,738

 

Age, years (mean)

28.9

29.4

29.4

<0.0001

Gender, female (%)

49.6%

53.8%

55.1%

<0.0001

Number of GP visits (mean)

5.5

7.7

6.6

<0.0001

Prescribed therapy

Number of respiratory medication prescriptions (mean)

3.6

12.9

6.9

<0.0001

Patients with ≥ 1 prescription of LABA-

-

41.1%

44.3%

<0.0001

ICS fixed combination (%)

    

Number of short-acting beta agonists prescriptions (mean)

3.4

6.7

2.7

<0.0001

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

6.2%

22.5%

12.7%

<0.0001

Number of prescriptions (mean)

0.1

0.5

0.2

<0.0001

Antibiotics (a)

    

Patients with ≥ 1 prescription (%)

34.5%

47.9%

41.4%

<0.0001

Number of prescriptions (mean)

0.7

1

0.8

<0.0001

Patients with at least 6 prescriptions of respiratory medications in 2008

Number of patients

1,384

11,835

8,391

 

Systemic corticosteroids

    

Patients with ≥ 1 prescription (%)

8.2%

24.6%

15.5%

<0.0001

Number of prescriptions (mean)

0.2

0.5

0.3

<0.0001

Antibiotics (a)

    

Patients with ≥ 1 prescription (%)

35%

49.3%

44.8%

<0.0001

Number of prescriptions (mean)

0.8

1.1

0.9

<0.0001

  1. (a)Beta-lactams, cephalosporins (first to third generation), macrolides and fluoroquinolones.